Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older
Clinical trial NCT06118151 · COMPLETED
Trial details
- NCT number
- NCT06118151
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-02-17
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.